Pioneering diagnostics
E.g., 25/05/2015
E.g., 25/05/2015

bioMérieux - First-Quarter 2015 Business Review

23 April, 2015

Strong growth in sales

  • €448 million in sales

  • Up 20.8% as reported

  • ...

BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel

14 April, 2015

Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a de novo classification request to the U.S. Food and Drug...

2014 Financial Results

11 March, 2015

Solid growth in sales:

  • Up 8.7%, including BioFire and at constant exchange rates
  • Up 3.8%, at constant exchange rates and scope of consolidation

Contributive operating income before non-recurring items*:...

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

26 February, 2015

New system delivers higher throughput, single database management and minimized footprint

Marcy l’Etoile, France – February 26, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire...

BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test

10 February, 2015

BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product...

Business Review for the Three Months and Full Year Ended December 31, 2014

22 January, 2015

Sales: solid growth, lifted sharply by BioFire

  • Revenue: €1,698 million, up a reported 7%
  • Up 8.7%, including BioFire and at constant exchange rates
  • Up 3.8% at constant exchange rates and scope of consolidation, in line with...

bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury

22 January, 2015

Marcy l’Etoile, (France) - San Diego, California (United States) - January 22, 2015 - bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and...

Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency

bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision

09 January, 2015

Marcy l’Etoile (France) - Brescia (Italy), January 9, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce that they have signed a strategic...

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

18 November, 2014

Marcy l’Etoile, FranceSan Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an...

BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test

27 October, 2014

Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for its commercial FilmArray...